Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Clever Climate Control
- This article briefs about two companies from Sweden and Germany, which met through the IRC network, and are together making 'smarter', smaller HVAC units to meet this growing market. More and more people expect to live and work in comfortable indoor temperatures and clean air all the year round. As...
- White papers 2003-11-27
- Turn Customer Input into Innovation
- How do you launch a blockbuster product? Stop asking customers what they want. Start asking what they want your products to do for them. That's how medical-device maker Cordis created the artery stent--which doubled the...
- Articles 2008-05-06
Additional Resources
- Takeover Talk Fuels Rallies of Cordis, Ivax Stocks.(Originated from The Miami Herald)
- Sept. 27--A slew of good corporate news and healthy doses of takeover speculation have sent Ivax and Cordis shares on a wild ride in recent months. Cordis' shares rallied $1.50 to close at $84 Tuesday after hitting a 52- week high of $85.12 earlier in Sept. 27--A...
- Research articles 1995-09-27
- Johnson & Johnson Extends Review Period for Takeover; Cordis Stock Tumbles.(Originated from The Miami Herald)
- Dec. 28--Johnson & Johnson said Wednesday it needs more time to study its planned takeover of Cordis, triggering an 11 percent drop in the price of Cordis shares. Dec. 28--Johnson & Johnson said Wednesday it needs more time to study its planned takeover of Cordis, triggering...
- Research articles 1995-12-27
- Cordis Corporation
- This case study describes about solar systems deployed by Johnson & Johnson. Johnson & Johnson, pleased with the performance of its solar systems at Neutrogena in California and PSGA/Ortho-McNeil Pharmaceuticals in Pennsylvania, decided to deploy a new solar electric system at the Cordis facility. Cordis Corporation, the world's leading developer...
- Case studies
- Medinol wins patent infringement suit against Cordis.
- Medinol (Tel Aviv, Israel) announced that the Court of Appeals in The Hague, Netherlands rendered a decision in its favor that finds the design of the BX-Velocity stent of up to 4 mm diameter infringes Medinol intellectual property. The court ordered Cordis Europe N.V. and Cordis...
- Research articles 2003-06-01
- Endosonics and Cordis sign a multi-year distribution and development agreement
- PLEASANTON, Calif.--BUSINESS WIRE--Feb. 6, 1996--Endosonics Corp. (NASDAQ:ESON) announced today that it signed a three year agreement with Cordis Corp. (NASDAQ:CORD) which extends the product distribution relationship established in 1994.The agreement gives Cordis exclusive distribution rights in North America and Europe covering the Company's intravascular ultrasound IVUS imaging equipment and catheter...
- Research articles 1996-02-06
- BMC Industries Announces Development and Supply Agreement With Cordis Corporation
- Business Editors MINNEAPOLIS--BUSINESS WIRE--March 29, 2001 BMC Industries, Inc. (NYSE: BMM) announced today that it has entered into an exclusive development and supply agreement with Cordis Corporation, a wholly-owned unit of Johnson & Johnson (NYSE: JNJ) and a global leader in developing and marketing devices for circulatory disease...
- Research articles 2001-03-29
- PEMSTAR to Provide Equipment and Manufacturing Services for Cordis Corporation's CYPHER Sirolimus-eluting Stent
- Business Editors ROCHESTER, Minn.--BUSINESS WIRE--June 4, 2002 PEMSTAR Inc. (Nasdaq:PMTR), a leading provider of global engineering, manufacturing and fulfillment services, announced today an exclusive agreement to provide production equipment and manufacturing services for Cordis Corporation's CYPHERTM Sirolimus-eluting Stenta program. Cordis Corporation is a Johnson & Johnson company. ...
- Research articles 2002-06-04
- PaineWebber Inc. adds Betz Laboratories, Readers Digest, Cordis Corp. and ITT Corp. to its focus list
- NEW YORK--BUSINESS WIRE--Dec. 28, 1994--PaineWebber Inc. announced today that it has added Betz Laboratories (NYSE:BTL), Readers Digest (NYSE:RDA), Cordis Corp. (NYSE:CORD) and ITT Corp. (NYSE:ITT) to its group of stocks known as the PaineWebber Focus List.
- Research articles 1994-12-28
- IT&E International Announces Long-term, Multi-country Contract with Johnson & Johnson's Subsidiary — Cordis Corporation
- SAN DIEGO -- IT&E International Group (OTCBB:ITER), announced today that it has signed a long-term, multi-country agreement with Cordis Corporation, a Johnson & Johnson (NYSE:JNJ) company, for expanded FDA regulatory compliance services.
- Research articles 2004-08-31
- Johnson & Johnson bid $1.6 billion for Cordis Corp.
- Forever changing its mild image as a manufacturer of baby products, health care giant Johnson and Johnson, based in New Brunswick, N.J., has made an unprecedented $1.6 billion hostile takeover bid for Cordis Corp., a Florida-based manufacturer of heart instruments. This all-cash tender offer translates to $100 a share. Johnson...
- Research articles 1995-10-30
- JOHNSON & JOHNSON'S CORDIS
- JOHNSON & JOHNSON'S CORDIS extended its DTC campaign for its Cypher stent onto the airwaves with a TV spot bearing the tagline: "Life wide open." The "Manifesto" ad, which debuted during the Thanksgiving Jets-Cowboys game, opens on a middle-aged man sinking, defeated, into an armchair to the strains of Guster's...
- Research articles 2008-01-01
- Cordis Corporation Receives U.S. Food and Drug Administration Clearance for S.M.A.R.T. Nitinol Stent Transhepatic Biliary System for 120 mm and 150 mm Lengths
- WASHINGTON -- Cordis Corporation announced today at the 33rd Annual Scientific Meeting of the Society of Interventional Radiology meeting it has received 510k marketing clearance from the U.S. Food and Drug Administration for the S.M.A.R.T.[R] Nitinol Stent Transhepatic Biliary System for lengths of 120 mm and 150 mm. These stents...
- Research articles 2008-03-17
- Research and Markets: Cordis Medical Device Company May Be Expanding at the Beginning of 2007 Through J&J's Planned Acquisition of Conor Medsystems for Approximately US$1.4 Billion
- DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c47899) has announced the addition of Cordis Medical Device Company Intelligence Report from Espicom Business Intelligence to their offering.
- Research articles 2007-01-04
- Judge Rules on Medtronic, Cordis Motions
- MINNEAPOLIS -- Medtronic, Inc. (NYSE:MDT) today confirmed that Judge Sue Robinson, U.S. District Court of Delaware, has ruled on post-trial motions by both Medtronic and Cordis Corporation, a subsidiary of Johnson & Johnson, in a patent infringement case known as Palmaz I that involves stent products no longer manufactured by...
- Research articles 2006-03-28
- Abbott Signs Agreement with American Red Cross for Blood Screening and J&J's Cordis Gets EU OK for Leg Stent.
- M2 PRESSWIRE-7 September 2006-U.S. Equity News: Abbott Signs Agreement with American Red Cross for Blood Screening and J&J's Cordis Gets EU OK for Leg StentC1994-2006 M2 COMMUNICATIONS LTD RDATE:07092006 City of Industry, CA - Pharmaceuticals Instruments industry alert provided by U.S....
- Research articles 2006-09-07
- INVITATION TO TENDER FOR SERVICE CONTRACTS RELATING TO CORDIS.
- The Enterprise DG of the European Commission has issued prior information on an invitation to tender for service contracts relating to CORDIS Community Research and Development Information Service, an activity of the programme for the promotion of innovation and encouragement of participation of SMEs. The contract...
- Research articles 2002-02-21
- COMMISSION PUBLISHES TENDER FOR CORDIS SERVICE.(European Commission's Research and Development Information Service)
- CORDIS, the European Commission's Research and Development Information Service, is offering tenders for the provision of information about EU research, technological development and innovation activities. Existing activities will have to be taken over in a short period of time, not exceeding three months...
- Research articles 2002-11-28
- NEW THEMATIC CORDIS SERVICE ON SUSTAINABLE ENERGY SYSTEMS.
- CORDIS, the European Commission's Research and Development Information Service, has launched a dedicated service for research and specific support actions on non-nuclear energy issues. The new service, part of the Sixth Framework Programme (FP6) portal, offers central access to background information and funding opportunities (Euro 810...
- Research articles 2003-07-11
- << Previous
- page 1 of 1
- Next >>
